BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35023672)

  • 21. Assessing the Quality of Serological Testing in the COVID-19 Pandemic: Results of a European External Quality Assessment (EQA) Scheme for Anti-SARS-CoV-2 Antibody Detection.
    Ast V; Costina V; Eichner R; Bode A; Aida S; Gerhards C; Thiaucourt M; Dobler G; Geilenkeuser WJ; Wölfel R; Neumaier M; Haselmann V
    J Clin Microbiol; 2021 Aug; 59(9):e0055921. PubMed ID: 34190575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiologic Characteristics Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen-Based Test Results, Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) Cycle Threshold Values, Subgenomic RNA, and Viral Culture Results From University Testing.
    Ford L; Lee C; Pray IW; Cole D; Bigouette JP; Abedi GR; Bushman D; Delahoy MJ; Currie DW; Cherney B; Kirby MK; Fajardo GC; Caudill M; Langolf K; Kahrs J; Zochert T; Kelly P; Pitts C; Lim A; Aulik N; Tamin A; Harcourt JL; Queen K; Zhang J; Whitaker B; Browne H; Medrzycki M; Shewmaker PL; Bonenfant G; Zhou B; Folster JM; Bankamp B; Bowen MD; Thornburg NJ; Goffard K; Limbago B; Bateman A; Tate JE; Gieryn D; Kirking HL; Westergaard RP; Killerby ME;
    Clin Infect Dis; 2021 Sep; 73(6):e1348-e1355. PubMed ID: 33846714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testing.
    Haselmann V; Özçürümez MK; Klawonn F; Ast V; Gerhards C; Eichner R; Costina V; Dobler G; Geilenkeuser WJ; Wölfel R; Neumaier M
    Clin Chem Lab Med; 2020 Aug; 58(12):2121-2130. PubMed ID: 32853163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of commercial realtime reverse transcription PCR assays for the detection of SARS-CoV-2.
    Iglói Z; Leven M; Abdel-Karem Abou-Nouar Z; Weller B; Matheeussen V; Coppens J; Koopmans M; Molenkamp R
    J Clin Virol; 2020 Aug; 129():104510. PubMed ID: 32570045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The versatility of external quality assessment for the surveillance of laboratory and
    Buchta C; Camp JV; Jovanovic J; Chiba P; Puchhammer-Stöckl E; Mayerhofer M; Plicka H; Lercher A; Popa AM; Endler L; Bergthaler A; Huf W; Benka B; Delatour V; Müller MM; Griesmacher A; Aberle SW; Görzer I
    Clin Chem Lab Med; 2021 Sep; 59(10):1735-1744. PubMed ID: 34187131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A reverse-transcription recombinase-aided amplification assay for the rapid detection of N gene of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2).
    Wu T; Ge Y; Zhao K; Zhu X; Chen Y; Wu B; Zhu F; Zhu B; Cui L
    Virology; 2020 Oct; 549():1-4. PubMed ID: 32758712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Technical and health governance aspects of the External Quality Assessment Scheme for the SARS-CoV-2 molecular tests: institutional experience performed in all clinical laboratories of a Regional Health Service.
    Di Gaudio F; Brunacci G; Contino F; Gallo A; Centineo F
    Clin Chem Lab Med; 2023 Jan; 61(1):173-179. PubMed ID: 36114825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 Detection using Real Time PCR by a Commercial Diagnostic Kit.
    Roy S; Paul SK; Barman TK; Ahmed S; Haque N; Mazid R; Debnath P; Roy SA
    Mymensingh Med J; 2020 Jul; 29(3):596-600. PubMed ID: 32844799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19 in Thailand.
    Chaimayo C; Kaewnaphan B; Tanlieng N; Athipanyasilp N; Sirijatuphat R; Chayakulkeeree M; Angkasekwinai N; Sutthent R; Puangpunngam N; Tharmviboonsri T; Pongraweewan O; Chuthapisith S; Sirivatanauksorn Y; Kantakamalakul W; Horthongkham N
    Virol J; 2020 Nov; 17(1):177. PubMed ID: 33187528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis and validation of a highly sensitive one-step nested quantitative real-time polymerase chain reaction assay for specific detection of severe acute respiratory syndrome coronavirus 2.
    Zhang Y; Dai C; Wang H; Gao Y; Li T; Fang Y; Shen Z; Chen L; Chen Z; Ma X; Li M
    Virol J; 2020 Dec; 17(1):197. PubMed ID: 33371898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of mobile real-time polymerase chain reaction tests for the detection of severe acute respiratory syndrome coronavirus 2.
    Onyilagha C; Mistry H; Marszal P; Pinette M; Kobasa D; Tailor N; Berhane Y; Nfon C; Pickering B; Mubareka S; Bulir D; Chong S; Kozak R; Ambagala A
    Sci Rep; 2021 Apr; 11(1):9387. PubMed ID: 33931684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SARS-CoV-2 E Gene Variant Alters Analytical Sensitivity Characteristics of Viral Detection Using a Commercial Reverse Transcription-PCR Assay.
    Tahan S; Parikh BA; Droit L; Wallace MA; Burnham CD; Wang D
    J Clin Microbiol; 2021 Jun; 59(7):e0007521. PubMed ID: 33903167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Limit of Detection Matters: The Case for Benchmarking Severe Acute Respiratory Syndrome Coronavirus 2 Testing.
    Arnaout R; Lee RA; Lee GR; Callahan C; Cheng A; Yen CF; Smith KP; Arora R; Kirby JE
    Clin Infect Dis; 2021 Nov; 73(9):e3042-e3046. PubMed ID: 33532847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. External Quality Assessment of MERS-CoV Molecular Diagnostics During the 2015 Korean Outbreak.
    Seong MW; Lee SJ; Cho SI; Ko K; Kim MN; Sung H; Kim JS; Ahn JS; Yu BS; Kim TS; Kim EC; Park SS
    Ann Lab Med; 2016 May; 36(3):230-4. PubMed ID: 26915611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis of the main haematological indexes and RNA detection for the diagnosis of SARS-CoV-2 infection.
    Xiang J; Chen Z; Zhou J; Tian D; Ran X; Zhang Z; Shi S; Xiao D; Zhou Y
    BMC Infect Dis; 2020 Oct; 20(1):779. PubMed ID: 33081702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Digital Droplet PCR for SARS-CoV-2 Resolves Borderline Cases.
    Xu J; Kirtek T; Xu Y; Zheng H; Yao H; Ostman E; Oliver D; Malter JS; Gagan JR; SoRelle JA
    Am J Clin Pathol; 2021 May; 155(6):815-822. PubMed ID: 33822853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of a SARS-CoV-2 virus genome detection external quality assessment round focusing on sensitivity of assays and pooling of samples.
    Buchta C; Camp JV; Jovanovic J; Puchhammer-Stöckl E; Strassl R; Müller MM; Griesmacher A; Aberle SW; Görzer I
    Clin Chem Lab Med; 2022 Jul; 60(8):1308-1312. PubMed ID: 35599330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical evaluation of a multiplex real-time RT-PCR assay for detection of SARS-CoV-2 in individual and pooled upper respiratory tract samples.
    Laverack M; Tallmadge RL; Venugopalan R; Cronk B; Zhang X; Rauh R; Saunders A; Nelson WM; Plocharczyk E; Diel DG
    Arch Virol; 2021 Sep; 166(9):2551-2561. PubMed ID: 34259914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proficiency testing for SARS-CoV-2 in assuring the quality and overall performance in viral RNA detection in clinical and public health laboratories.
    Lau KA; Kaufer A; Gray J; Theis T; Rawlinson WD
    Pathology; 2022 Jun; 54(4):472-478. PubMed ID: 35440366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of SARS-CoV-2 RNA and nucleocapsid concentrations in samples used in INSTAND external quality assessment schemes.
    Valiente E; Falak S; Kummrow A; Kammel M; Corman VM; Macdonald R; Zeichhardt H
    BMC Res Notes; 2023 Sep; 16(1):210. PubMed ID: 37697348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.